“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart
Article: P.16 Expression of TMEM45A, a candidate gene of chemoresistance, in a panel of neoplastic tissues
Reviews
There are no reviews yet.